Abstract:Abstract Background: Previous studies have revealed esophageal dysplasia, a precancerous lesion of ESCC, harbors similar mutations and markers of genomic instability as ESCC does. This observation suggests that other factors such as evasion of immune surveillance may be involved in the progression of esophageal dysplasia to ESCC. The study aimed to identify the key differences in the immune TME between esophageal dysplasia and ESCC. Methods: Patients with a history of diagnosing with esophageal dysplasia for at least two times prior to the diagnosis of ESCC were enrolled. Formalin-fixed paraffin-embedded tissues from esophageal dysplasia diagnosed more than 6 months prior to the diagnosis of ESCC (denoted as dysplasia-1), esophageal dysplasia diagnosed within 6 months prior to the diagnosis of ESCC (denoted as dysplasia-2), and ESCC were retrieved. Transcriptomic data of esophageal dysplasia and ESCC tissues were generated by NanoString nCounter platform with Human PanCancer Immune Profiling panel, and were further analyzed for the expression levels of infiltrating immune cells by CIBERSORT. Results Six ESCC patients (M:F= 6:0), with median age of 56.6 (range: 43.3-79.1) years, were enrolled. The median time between the diagnosis of dysplasia-1 and that of ESCC was 10.2 months (range 6.0-38.6) and the median time between the diagnosis of dysplasia-2 and that of ESCC was 2.3 months (range 0.0-6.0). The analysis of immune cell signatures defined by NanoString platform revealed that multiple cell types were significantly increased in ESCC compared with dysplasia-1 (mast cell, macrophage, CD8 T cell, B cell and dendritic cell, all P < 0.05) and in ESCC compared with dysplasia-2 (macrophage, mast cell, dendritic cell, B cell, T cell, CD4 T cell, regulatory T cell, cytotoxic T cell, NK CD56dim cell, and T helper cell, all P < 0.05). There was no significant difference in the immune cell signatures between dysplasia-1 and dysplasia-2. Immune cells classified by CIBERSORT showed an increase of M2 macrophage and a decrease of M1/M2 ratio in ESCC compared with dysplasia-1 or dysplasia-2 (both P < 0.05). Conclusions: Our data, showing an increase of M2 macrophage in TME of ESCC compared with its precancerous esophageal dysplasia, suggest that evolution of immune TME may play a role in the progression of esophageal dysplasia to ESCC. (Funded by MOST 108-2314-B-002-076-MY3, MOST 109-2314-B-002-231-, MOHW 111-TDU-B-221-114006, NTUCCS-110-10, and NTUCCS-111-05) Citation Format: Jhe-Cyuan Guo, Chia-Lang Hsu, Yen-Lin Huang, Tsung-Che Wu, Chih-Hung Hsu. Evolution of immune tumor microenvironment (TME) from esophageal dysplasia to esophageal squamous cell carcinoma (ESCC) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1355.

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma

Subtypes of MDSCs in Mechanisms and Prognosis of Gastric Cancer and Are Inhibited by Epirubicin and Paclitaxel.

Increased Circulating GrMyeloid-derived Suppressor Cells Correlated with Tumor Burden and Survival in Locally Advanced Cervical Cancer Patient

Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma

Infiltration of Alternatively Activated Macrophages in Cancer Tissue Is Associated with MDSC and Th2 Polarization in Patients with Esophageal Cancer

Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms

The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction.

Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis

Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression

Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression

The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer

CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations

Abstract 1355: Evolution of immune tumor microenvironment (TME) from esophageal dysplasia to esophageal squamous cell carcinoma (ESCC)

A study of multinucleated giant cells in esophageal cancer

The combined action of monocytic myeloid-derived suppressor cells and mucosal-associated invariant T cells promotes the progression of cervical cancer

Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells

SMPDL3B contributes to gastric adenocarcinoma cells progression by promoting the infiltration of M2 macrophages